Davis, CA, United States of America

Ana Fidantsef

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ana Fidantsef: Pioneering Variants of Beta-Glucosidase

Introduction: Ana Fidantsef, a distinguished inventor based in Davis, California, has made significant contributions to the field of biotechnology. With a total of six patents to her name, Ana's work revolves around the innovative development of beta-glucosidase variants, showcasing her expertise and forward-thinking approach in this specialized area.

Latest Patents: Among Ana Fidantsef’s latest innovations are her patented variants of beta-glucosidase. These inventions pertain to variants of a parent beta-glucosidase that include specific amino acid substitutions at various positions, such as 142, 183, 266, and 703 of amino acids 1 to 842 of SEQ ID NO: 2, and positions 142, 183, 266, and 705 of amino acids 1 to 844 of SEQ ID NO: 70. These variants not only retain beta-glucosidase activity but also extend the understanding and application of this enzyme. Ana's patents further detail nucleotide sequences encoding these variants, as well as nucleic acid constructs, vectors, and host cells that incorporate the nucleotide sequences.

Career Highlights: Ana Fidantsef is currently employed at Novozymes, Inc., a company known for its focus on biological solutions. Her career has been marked by a commitment to advancing the science of enzymology, which is exemplified by her innovative patents on beta-glucosidase variants. This dedication to research enhances the practical applications of her work in various industries, including biofuels and pharmaceuticals.

Collaborations: Throughout her career, Ana has partnered with notable colleagues, including Michael Lamsa and Brian Gorre-Clancy. Their collaborative efforts have helped propel significant advancements in biotechnology, allowing for the exploration of new applications and improving existing processes within the sector.

Conclusion: Ana Fidantsef stands out as a remarkable inventor whose contributions are setting new standards in biotechnology. With her advancements in beta-glucosidase variants, she is not only paving the way for future innovations but also inspiring the next generation of scientists and inventors in this exciting field. Her work at Novozymes, Inc. and collaborations with esteemed coworkers reinforce her status as a leading figure in the biotechnology community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…